 | • レポートコード：QFJ1-5584 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、抗糖尿病薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、その他）、用途別市場規模（糖尿病予防・治療、肥満治療、心臓血管保護、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗糖尿病薬の市場動向 ・企業の競争状況、市場シェア ・抗糖尿病薬の種類別市場規模と予測2016-2027（経口、注射、その他） ・抗糖尿病薬の用途別市場規模と予測2016-2027（糖尿病予防・治療、肥満治療、心臓血管保護、その他） ・抗糖尿病薬の北米市場規模2016-2027（アメリカ、カナダ） ・抗糖尿病薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗糖尿病薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗糖尿病薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗糖尿病薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck Sharp & Dohme、Lilly、Novo Nordisk、Huadong Medicine、Bayer、Oddway International、Luye、Uni-Bio Group） ・結論 |
Market Analysis and Insights: Global Anti-diabetic Medication Market
The global Anti-diabetic Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-diabetic Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-diabetic Medication market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-diabetic Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-diabetic Medication market.
Global Anti-diabetic Medication Scope and Market Size
Anti-diabetic Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-diabetic Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injection
Other
Segment by Application
Prevent and Treatment Diabetes
Obesity Treatment
Cardiovascular Protection
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck Sharp & Dohme
Lilly
Novo Nordisk
Huadong Medicine
Bayer
Oddway International
Luye
Uni-Bio Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-diabetic Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Anti-diabetic Medication Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Prevent and Treatment Diabetes
1.3.3 Obesity Treatment
1.3.4 Cardiovascular Protection
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-diabetic Medication Market Perspective (2016-2027)
2.2 Anti-diabetic Medication Growth Trends by Regions
2.2.1 Anti-diabetic Medication Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-diabetic Medication Historic Market Share by Regions (2016-2021)
2.2.3 Anti-diabetic Medication Forecasted Market Size by Regions (2022-2027)
2.3 Anti-diabetic Medication Industry Dynamic
2.3.1 Anti-diabetic Medication Market Trends
2.3.2 Anti-diabetic Medication Market Drivers
2.3.3 Anti-diabetic Medication Market Challenges
2.3.4 Anti-diabetic Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-diabetic Medication Players by Revenue
3.1.1 Global Top Anti-diabetic Medication Players by Revenue (2016-2021)
3.1.2 Global Anti-diabetic Medication Revenue Market Share by Players (2016-2021)
3.2 Global Anti-diabetic Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-diabetic Medication Revenue
3.4 Global Anti-diabetic Medication Market Concentration Ratio
3.4.1 Global Anti-diabetic Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-diabetic Medication Revenue in 2020
3.5 Anti-diabetic Medication Key Players Head office and Area Served
3.6 Key Players Anti-diabetic Medication Product Solution and Service
3.7 Date of Enter into Anti-diabetic Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-diabetic Medication Breakdown Data by Type
4.1 Global Anti-diabetic Medication Historic Market Size by Type (2016-2021)
4.2 Global Anti-diabetic Medication Forecasted Market Size by Type (2022-2027)
5 Anti-diabetic Medication Breakdown Data by Application
5.1 Global Anti-diabetic Medication Historic Market Size by Application (2016-2021)
5.2 Global Anti-diabetic Medication Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-diabetic Medication Market Size (2016-2027)
6.2 North America Anti-diabetic Medication Market Size by Type
6.2.1 North America Anti-diabetic Medication Market Size by Type (2016-2021)
6.2.2 North America Anti-diabetic Medication Market Size by Type (2022-2027)
6.2.3 North America Anti-diabetic Medication Market Size by Type (2016-2027)
6.3 North America Anti-diabetic Medication Market Size by Application
6.3.1 North America Anti-diabetic Medication Market Size by Application (2016-2021)
6.3.2 North America Anti-diabetic Medication Market Size by Application (2022-2027)
6.3.3 North America Anti-diabetic Medication Market Size by Application (2016-2027)
6.4 North America Anti-diabetic Medication Market Size by Country
6.4.1 North America Anti-diabetic Medication Market Size by Country (2016-2021)
6.4.2 North America Anti-diabetic Medication Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-diabetic Medication Market Size (2016-2027)
7.2 Europe Anti-diabetic Medication Market Size by Type
7.2.1 Europe Anti-diabetic Medication Market Size by Type (2016-2021)
7.2.2 Europe Anti-diabetic Medication Market Size by Type (2022-2027)
7.2.3 Europe Anti-diabetic Medication Market Size by Type (2016-2027)
7.3 Europe Anti-diabetic Medication Market Size by Application
7.3.1 Europe Anti-diabetic Medication Market Size by Application (2016-2021)
7.3.2 Europe Anti-diabetic Medication Market Size by Application (2022-2027)
7.3.3 Europe Anti-diabetic Medication Market Size by Application (2016-2027)
7.4 Europe Anti-diabetic Medication Market Size by Country
7.4.1 Europe Anti-diabetic Medication Market Size by Country (2016-2021)
7.4.2 Europe Anti-diabetic Medication Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-diabetic Medication Market Size (2016-2027)
8.2 Asia-Pacific Anti-diabetic Medication Market Size by Type
8.2.1 Asia-Pacific Anti-diabetic Medication Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-diabetic Medication Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-diabetic Medication Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-diabetic Medication Market Size by Application
8.3.1 Asia-Pacific Anti-diabetic Medication Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-diabetic Medication Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-diabetic Medication Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-diabetic Medication Market Size by Region
8.4.1 Asia-Pacific Anti-diabetic Medication Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-diabetic Medication Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-diabetic Medication Market Size (2016-2027)
9.2 Latin America Anti-diabetic Medication Market Size by Type
9.2.1 Latin America Anti-diabetic Medication Market Size by Type (2016-2021)
9.2.2 Latin America Anti-diabetic Medication Market Size by Type (2022-2027)
9.2.3 Latin America Anti-diabetic Medication Market Size by Type (2016-2027)
9.3 Latin America Anti-diabetic Medication Market Size by Application
9.3.1 Latin America Anti-diabetic Medication Market Size by Application (2016-2021)
9.3.2 Latin America Anti-diabetic Medication Market Size by Application (2022-2027)
9.3.3 Latin America Anti-diabetic Medication Market Size by Application (2016-2027)
9.4 Latin America Anti-diabetic Medication Market Size by Country
9.4.1 Latin America Anti-diabetic Medication Market Size by Country (2016-2021)
9.4.2 Latin America Anti-diabetic Medication Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-diabetic Medication Market Size (2016-2027)
10.2 Middle East & Africa Anti-diabetic Medication Market Size by Type
10.2.1 Middle East & Africa Anti-diabetic Medication Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-diabetic Medication Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-diabetic Medication Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-diabetic Medication Market Size by Application
10.3.1 Middle East & Africa Anti-diabetic Medication Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-diabetic Medication Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-diabetic Medication Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-diabetic Medication Market Size by Country
10.4.1 Middle East & Africa Anti-diabetic Medication Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-diabetic Medication Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck Sharp & Dohme
11.1.1 Merck Sharp & Dohme Company Details
11.1.2 Merck Sharp & Dohme Business Overview
11.1.3 Merck Sharp & Dohme Anti-diabetic Medication Introduction
11.1.4 Merck Sharp & Dohme Revenue in Anti-diabetic Medication Business (2016-2021)
11.1.5 Merck Sharp & Dohme Recent Development
11.2 Lilly
11.2.1 Lilly Company Details
11.2.2 Lilly Business Overview
11.2.3 Lilly Anti-diabetic Medication Introduction
11.2.4 Lilly Revenue in Anti-diabetic Medication Business (2016-2021)
11.2.5 Lilly Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Anti-diabetic Medication Introduction
11.3.4 Novo Nordisk Revenue in Anti-diabetic Medication Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Huadong Medicine
11.4.1 Huadong Medicine Company Details
11.4.2 Huadong Medicine Business Overview
11.4.3 Huadong Medicine Anti-diabetic Medication Introduction
11.4.4 Huadong Medicine Revenue in Anti-diabetic Medication Business (2016-2021)
11.4.5 Huadong Medicine Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Anti-diabetic Medication Introduction
11.5.4 Bayer Revenue in Anti-diabetic Medication Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Oddway International
11.6.1 Oddway International Company Details
11.6.2 Oddway International Business Overview
11.6.3 Oddway International Anti-diabetic Medication Introduction
11.6.4 Oddway International Revenue in Anti-diabetic Medication Business (2016-2021)
11.6.5 Oddway International Recent Development
11.7 Luye
11.7.1 Luye Company Details
11.7.2 Luye Business Overview
11.7.3 Luye Anti-diabetic Medication Introduction
11.7.4 Luye Revenue in Anti-diabetic Medication Business (2016-2021)
11.7.5 Luye Recent Development
11.8 Uni-Bio Group
11.8.1 Uni-Bio Group Company Details
11.8.2 Uni-Bio Group Business Overview
11.8.3 Uni-Bio Group Anti-diabetic Medication Introduction
11.8.4 Uni-Bio Group Revenue in Anti-diabetic Medication Business (2016-2021)
11.8.5 Uni-Bio Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-diabetic Medication Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Other
Table 5. Global Anti-diabetic Medication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-diabetic Medication Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-diabetic Medication Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anti-diabetic Medication Market Share by Regions (2016-2021)
Table 9. Global Anti-diabetic Medication Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anti-diabetic Medication Market Share by Regions (2022-2027)
Table 11. Anti-diabetic Medication Market Trends
Table 12. Anti-diabetic Medication Market Drivers
Table 13. Anti-diabetic Medication Market Challenges
Table 14. Anti-diabetic Medication Market Restraints
Table 15. Global Anti-diabetic Medication Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anti-diabetic Medication Market Share by Players (2016-2021)
Table 17. Global Top Anti-diabetic Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-diabetic Medication as of 2020)
Table 18. Ranking of Global Top Anti-diabetic Medication Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anti-diabetic Medication Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-diabetic Medication Product Solution and Service
Table 22. Date of Enter into Anti-diabetic Medication Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-diabetic Medication Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anti-diabetic Medication Revenue Market Share by Type (2016-2021)
Table 26. Global Anti-diabetic Medication Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anti-diabetic Medication Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anti-diabetic Medication Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anti-diabetic Medication Revenue Market Share by Application (2016-2021)
Table 30. Global Anti-diabetic Medication Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anti-diabetic Medication Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anti-diabetic Medication Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anti-diabetic Medication Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anti-diabetic Medication Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anti-diabetic Medication Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-diabetic Medication Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anti-diabetic Medication Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anti-diabetic Medication Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anti-diabetic Medication Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anti-diabetic Medication Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anti-diabetic Medication Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anti-diabetic Medication Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anti-diabetic Medication Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anti-diabetic Medication Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anti-diabetic Medication Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti-diabetic Medication Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti-diabetic Medication Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-diabetic Medication Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anti-diabetic Medication Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anti-diabetic Medication Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anti-diabetic Medication Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anti-diabetic Medication Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anti-diabetic Medication Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anti-diabetic Medication Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anti-diabetic Medication Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anti-diabetic Medication Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anti-diabetic Medication Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti-diabetic Medication Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti-diabetic Medication Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-diabetic Medication Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anti-diabetic Medication Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck Sharp & Dohme Company Details
Table 63. Merck Sharp & Dohme Business Overview
Table 64. Merck Sharp & Dohme Anti-diabetic Medication Product
Table 65. Merck Sharp & Dohme Revenue in Anti-diabetic Medication Business (2016-2021) & (US$ Million)
Table 66. Merck Sharp & Dohme Recent Development
Table 67. Lilly Company Details
Table 68. Lilly Business Overview
Table 69. Lilly Anti-diabetic Medication Product
Table 70. Lilly Revenue in Anti-diabetic Medication Business (2016-2021) & (US$ Million)
Table 71. Lilly Recent Development
Table 72. Novo Nordisk Company Details
Table 73. Novo Nordisk Business Overview
Table 74. Novo Nordisk Anti-diabetic Medication Product
Table 75. Novo Nordisk Revenue in Anti-diabetic Medication Business (2016-2021) & (US$ Million)
Table 76. Novo Nordisk Recent Development
Table 77. Huadong Medicine Company Details
Table 78. Huadong Medicine Business Overview
Table 79. Huadong Medicine Anti-diabetic Medication Product
Table 80. Huadong Medicine Revenue in Anti-diabetic Medication Business (2016-2021) & (US$ Million)
Table 81. Huadong Medicine Recent Development
Table 82. Bayer Company Details
Table 83. Bayer Business Overview
Table 84. Bayer Anti-diabetic Medication Product
Table 85. Bayer Revenue in Anti-diabetic Medication Business (2016-2021) & (US$ Million)
Table 86. Bayer Recent Development
Table 87. Oddway International Company Details
Table 88. Oddway International Business Overview
Table 89. Oddway International Anti-diabetic Medication Product
Table 90. Oddway International Revenue in Anti-diabetic Medication Business (2016-2021) & (US$ Million)
Table 91. Oddway International Recent Development
Table 92. Luye Company Details
Table 93. Luye Business Overview
Table 94. Luye Anti-diabetic Medication Product
Table 95. Luye Revenue in Anti-diabetic Medication Business (2016-2021) & (US$ Million)
Table 96. Luye Recent Development
Table 97. Uni-Bio Group Company Details
Table 98. Uni-Bio Group Business Overview
Table 99. Uni-Bio Group Revenue in Anti-diabetic Medication Business (2016-2021) & (US$ Million)
Table 100. Uni-Bio Group Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-diabetic Medication Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Other Features
Figure 5. Global Anti-diabetic Medication Market Share by Application: 2020 VS 2027
Figure 6. Prevent and Treatment Diabetes Case Studies
Figure 7. Obesity Treatment Case Studies
Figure 8. Cardiovascular Protection Case Studies
Figure 9. Other Case Studies
Figure 10. Anti-diabetic Medication Report Years Considered
Figure 11. Global Anti-diabetic Medication Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anti-diabetic Medication Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anti-diabetic Medication Market Share by Regions: 2020 VS 2027
Figure 14. Global Anti-diabetic Medication Market Share by Regions (2022-2027)
Figure 15. Global Anti-diabetic Medication Market Share by Players in 2020
Figure 16. Global Top Anti-diabetic Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-diabetic Medication as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anti-diabetic Medication Revenue in 2020
Figure 18. Global Anti-diabetic Medication Revenue Market Share by Type (2016-2021)
Figure 19. Global Anti-diabetic Medication Revenue Market Share by Type (2022-2027)
Figure 20. North America Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anti-diabetic Medication Market Share by Type (2016-2027)
Figure 22. North America Anti-diabetic Medication Market Share by Application (2016-2027)
Figure 23. North America Anti-diabetic Medication Market Share by Country (2016-2027)
Figure 24. United States Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anti-diabetic Medication Market Share by Type (2016-2027)
Figure 28. Europe Anti-diabetic Medication Market Share by Application (2016-2027)
Figure 29. Europe Anti-diabetic Medication Market Share by Country (2016-2027)
Figure 30. Germany Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anti-diabetic Medication Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anti-diabetic Medication Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anti-diabetic Medication Market Share by Region (2016-2027)
Figure 40. China Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anti-diabetic Medication Market Share by Type (2016-2027)
Figure 48. Latin America Anti-diabetic Medication Market Share by Application (2016-2027)
Figure 49. Latin America Anti-diabetic Medication Market Share by Country (2016-2027)
Figure 50. Mexico Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anti-diabetic Medication Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anti-diabetic Medication Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anti-diabetic Medication Market Share by Country (2016-2027)
Figure 56. Turkey Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anti-diabetic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Merck Sharp & Dohme Revenue Growth Rate in Anti-diabetic Medication Business (2016-2021)
Figure 60. Lilly Revenue Growth Rate in Anti-diabetic Medication Business (2016-2021)
Figure 61. Novo Nordisk Revenue Growth Rate in Anti-diabetic Medication Business (2016-2021)
Figure 62. Huadong Medicine Revenue Growth Rate in Anti-diabetic Medication Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Anti-diabetic Medication Business (2016-2021)
Figure 64. Oddway International Revenue Growth Rate in Anti-diabetic Medication Business (2016-2021)
Figure 65. Luye Revenue Growth Rate in Anti-diabetic Medication Business (2016-2021)
Figure 66. Uni-Bio Group Revenue Growth Rate in Anti-diabetic Medication Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…- 世界の注射式しわ治療市場規模・現状・予測（2021年-2027年） Injectable anti –wrinkle are the treatment that are injected into the treatment area to reduce the skin lines and wrinkles. It can also fill the sagging skin and tighten the skin, reduce the frown lines, and lines under the eyes etc. The injectable anti-wrinkle treatment can help in rejuvenation of …
- 世界の経口抗糖尿病薬市場規模・現状・予測（2021年-2027年） Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels …
- 世界の糖尿病性潰瘍治療市場規模・現状・予測（2021年-2027年） Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Market Analysis and Insights: Global Diabetic Ulcers Treatment Market The global Diabetic Ulcers Treatment market size is projected to reach US$ 9041.7 million by 2027, from US$ 6…
- 世界の転移性骨疾患薬物治療市場規模・現状・予測（2021年-2027年） Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. Market Analysis and Insights: Global Medication Treatment …